Sysmex (OTCMKTS:SSMXY) Issues Earnings Results

Sysmex (OTCMKTS:SSMXY) announced its quarterly earnings results on Wednesday. The company reported $0.17 earnings per share (EPS) for the quarter, Zacks reports. Sysmex updated its FY 2024 guidance to 0.580-0.580 EPS.

Sysmex Trading Down 0.3 %

SSMXY stock traded down $0.06 during midday trading on Thursday, hitting $18.22. The stock had a trading volume of 75,584 shares, compared to its average volume of 84,987. The company’s 50-day moving average price is $18.86 and its 200 day moving average price is $19.02. The company has a debt-to-equity ratio of 0.11, a current ratio of 3.19 and a quick ratio of 2.42. Sysmex has a 12-month low of $14.38 and a 12-month high of $28.58. The firm has a market cap of $11.47 billion, a PE ratio of 36.91 and a beta of 0.90.

About Sysmex

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.